Journal
CELL METABOLISM
Volume 20, Issue 5, Pages 827-839Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.08.011
Keywords
-
Categories
Funding
- Canadian Institutes for Health Research
- Alberta Innovates-Health Solutions
- Alberta Innovates-Health Solutions, a Canada Research Chair
- Mazankowski Alberta Heart Institute/University Hospital Foundation
Ask authors/readers for more resources
Suppression of mitochondrial function promoting proliferation and apoptosis suppression has been described in the pulmonary arteries and extrapulmonary tissues in pulmonary arterial hypertension (PAH), but the cause of this metabolic remodeling is unknown. Mice lacking sirtuin 3 (SIRT3), a mitochondrial deacetylase, have increased acetylation and inhibition of many mitochondrial enzymes and complexes, suppressing mitochondrial function. Sirt3KO mice develop spontaneous PAH, exhibiting previously described molecular features of PAH pulmonary artery smooth muscle cells (PASMC). In human PAH PASMC and rats with PAH, SIRT3 is downregulated, and its normalization with adenovirus gene therapy reverses the disease phenotype. A loss-of-function SIRT3 polymorphism, linked to metabolic syndrome, is associated with PAH in an unbiased cohort of 162 patients and controls. If confirmed in large patient cohorts, these findings may facilitate biomarker and therapeutic discovery programs in PAH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available